Literature DB >> 6333894

Immune complexes in retinitis pigmentosa.

C D Heredia, J Huguet, N Cols, P Engel, P A García-Calderón.   

Abstract

In a group of 46 patients with retinitis pigmentosa (RP) we studied the presence of circulating immune complexes (CIC) and the alterations in the complement system. Our results showed the presence of CIC in 43.5% of the patients studied, reduced levels of the complement components C3 and C4 (p less than 0.001), and of the haemolytic activity CH50 (p less than 0.001) when compared with a control group consisting of a 100 healthy subjects. We found a statistically significant correlation between the values of C3 and CIC (p less than 0.01), C4 and CIC (p less than 0.01), and between CH50 and CIC (p less than 0.001). These findings indicate that the CIC may play a role in the pathogenesis of primary retinitis pigmentosa.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6333894      PMCID: PMC1040476          DOI: 10.1136/bjo.68.11.811

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  12 in total

1.  A new complement function: solubilization of antigen-antibody aggregates.

Authors:  G W Miller; V Nussenzweig
Journal:  Proc Natl Acad Sci U S A       Date:  1975-02       Impact factor: 11.205

2.  The nature of immune complexes in human cancer sera.

Authors:  A N Theofilopoulos; B S Andrews; M M Urist; D L Morton; F J Dixon
Journal:  J Immunol       Date:  1977-08       Impact factor: 5.422

3.  Immunological studies in retinitis pigmentosa associated with retinal vascular leakage.

Authors:  D J Spalton; A H Rahi; A C Bird
Journal:  Br J Ophthalmol       Date:  1978-03       Impact factor: 4.638

4.  Autoimmunity and the retina. II. Raised serum IgM levels in retinitis pigmentosa.

Authors:  A H Rahi
Journal:  Br J Ophthalmol       Date:  1973-12       Impact factor: 4.638

5.  Towards a network theory of the immune system.

Authors:  N K Jerne
Journal:  Ann Immunol (Paris)       Date:  1974-01

6.  Detection of immune complexes by a new assay, the polyethylene glycol precipitation-complement consumption test (PEG-CC).

Authors:  G D Harkiss; D L Brown
Journal:  Clin Exp Immunol       Date:  1979-04       Impact factor: 4.330

7.  Immune complexes in serum and in cerebrospinal fluid in African trypanosomiasis. Correlation with polyclonal B cell activation and with intracerebral immunoglobulin synthesis.

Authors:  P H Lambert; M Berney; G Kazyumba
Journal:  J Clin Invest       Date:  1981-01       Impact factor: 14.808

8.  Clinical relevance of circulating immune complexes in human leukemia. Association in acute leukemia of the presence of immune complexes with unfavorable prognosis.

Authors:  N A Carpentier; G T Lange; D M Fiere; G J Fournie; P H Lambert; P A Miescher
Journal:  J Clin Invest       Date:  1977-10       Impact factor: 14.808

9.  Retinitis pigmentosa and retinal oedema.

Authors:  D J Spalton; A C Bird; P E Cleary
Journal:  Br J Ophthalmol       Date:  1978-03       Impact factor: 4.638

10.  In situ immune complex formation in isolated perfused kidney using homologous antibody.

Authors:  S P Makker; B Moorthy
Journal:  Lab Invest       Date:  1981-01       Impact factor: 5.662

View more
  5 in total

1.  A novel role of complement in retinal degeneration.

Authors:  Minzhong Yu; Weilin Zou; Neal S Peachey; Thomas M McIntyre; Jinbo Liu
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-11-19       Impact factor: 4.799

Review 2.  Modulation of three key innate immune pathways for the most common retinal degenerative diseases.

Authors:  Isha Akhtar-Schäfer; Luping Wang; Tim U Krohne; Heping Xu; Thomas Langmann
Journal:  EMBO Mol Med       Date:  2018-10       Impact factor: 12.137

3.  RNA-seq analysis reveals differentially expressed inflammatory chemokines in a rat retinal degeneration model induced by sodium iodate.

Authors:  Sheng Chen; Guo Liu; Xin Liu; Yun Wang; Fen He; Danyao Nie; Xinhua Liu; Xuyang Liu
Journal:  J Int Med Res       Date:  2022-08       Impact factor: 1.573

4.  Targeting inflammation in emerging therapies for genetic retinal disease.

Authors:  Ishaq A Viringipurampeer; Abu E Bashar; Cheryl Y Gregory-Evans; Orson L Moritz; Kevin Gregory-Evans
Journal:  Int J Inflam       Date:  2013-02-21

Review 5.  Retinal Dystrophies and the Road to Treatment: Clinical Requirements and Considerations.

Authors:  Mays Talib; Camiel J F Boon
Journal:  Asia Pac J Ophthalmol (Phila)       Date:  2020 May-Jun
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.